Microscopic vascular invasion is associated with worse disease-free and recurrence-free survival in patients with localized and non-metastatic renal cell carcinoma, according to a stage-stratified systematic review and meta-analysis published in BMC Urology. Researchers Mohammed Sait and Fawaz Almutairi evaluated the prognostic significance of this pathological feature using multivariable-adjusted hazard ratios to address longstanding uncertainties in kidney cancer risk stratification.

The clinical impact of microscopic vascular invasion in renal cell carcinoma has historically remained difficult to interpret because earlier reviews pooled together heterogeneous definitions and mixed distinct cancer stages. Within the published literature, the condition has been variably identified as either lymphovascular invasion or microvascular invasion, creating ambiguity regarding its independent prognostic power.

To evaluate these outcomes across defined clinical stages, the investigators performed a comprehensive literature search across PubMed, Scopus, Web of Science, the Cochrane Library, ScienceDirect, and Google Scholar from database inception through October 2025. The study protocol was registered in the PROSPERO international prospective register of systematic reviews under registration number CRD420251147985.

Eligible investigations included adult cohorts with histologically confirmed renal cell carcinoma who underwent histopathological assessment for microscopic vascular invasion. The authors performed random-effects meta-analyses to pool multivariable-adjusted hazard ratios in localized and non-metastatic patient cohorts where renal-vein and renal-sinus involvement was either absent or analyzed separately. Harmonization between lymphovascular invasion and microvascular invasion definitions was treated as a working reporting assumption throughout the analysis.

A total of 57 publications met the inclusion criteria for the broader systematic review, with 13 studies contributing to the primary synthesis and 11 incorporated into pooled meta-analyses. The quantitative synthesis demonstrated that microscopic vascular invasion was associated with worse disease-free or recurrence-free survival in non-metastatic disease across five pooled studies, yielding a multivariable hazard ratio of 3.56 with a 95% confidence interval of 2.09 to 6.06 supported by moderate certainty evidence.

Among patients with localized disease, microscopic vascular invasion was similarly associated with shorter disease-free and recurrence-free survival across three studies, demonstrating a hazard ratio of 3.39 with a 95% confidence interval of 1.76 to 6.55, evaluated as low certainty evidence. A secondary overall analysis evaluating recurrence-free survival across seven studies revealed a comparable hazard ratio of 3.42 with a 95% confidence interval of 2.26 to 5.18 under moderate certainty.

In contrast to recurrence findings, cancer-specific survival estimates in non-metastatic renal cell carcinoma remained inconclusive across six studies, showing a hazard ratio of 1.19 with a 95% confidence interval of 0.91 to 1.55 under low certainty. Additionally, four localized cancer-specific survival estimates were omitted from pooling because all originated from sparse-event models with low events per variable, which introduced sparse-data bias and model instability rated as very low certainty.

The study authors concluded that although microscopic vascular invasion shows a clear statistical association with inferior recurrence outcomes in localized and non-metastatic renal cell carcinoma, the exact magnitude of this effect remains uncertain. They also cautioned that observed prognostic associations do not establish evidence of therapeutic benefit from adjuvant treatment.

Subject of Research: Prognostic significance of microscopic vascular invasion in renal cell carcinoma

Article Title: Prognostic impact of microscopic vascular invasion in renal cell carcinoma: a stage-stratified meta-analysis

Article References: Sait, M., & Almutairi, F. (2026). Prognostic impact of microscopic vascular invasion in renal cell carcinoma: a stage-stratified meta-analysis. BMC Urology. https://doi.org/10.1186/s12894-026-02404-x

Image Credits: AI Generated

DOI: 10.1186/s12894-026-02404-x

Keywords: renal cell carcinoma, microscopic vascular invasion, lymphovascular invasion, microvascular invasion, disease-free survival, recurrence-free survival, cancer-specific survival, stage-stratified meta-analysis, localized renal cell carcinoma, non-metastatic renal cell carcinoma, multivariable-adjusted hazard ratios, random-effects meta-analysis, sparse-data bias, adjuvant treatment, PROSPERO CRD420251147985, systematic review, histopathological assessment